Cargando…

Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation

BACKGROUND: Cystic fibrosis (CF) is characterized by recurrent pulmonary exacerbations (PEx) and lung function decline. PEx are frequently treated with antibiotics. However, little is known about the effects of antibiotics on the airway microbiome of persons with CF over time. The purpose of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inam, Zaina, Felton, Erin, Burrell, Aszia, Chaney, Hollis, Sami, Iman, Koumbourlis, Anastassios C, Freishtat, Robert J, Zemanick, Edith T, Crandall, Keith A, Hahn, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511275/ https://www.ncbi.nlm.nih.gov/pubmed/36168550 http://dx.doi.org/10.1093/ofid/ofac466

Ejemplares similares

Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis
por: Shumyatsky, Gabriella, et al.
Publicado: (2023)

Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2023)

Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2021)

Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids
por: Felton, Erin, et al.
Publicado: (2021)

Antibiotic multidrug resistance in the cystic fibrosis airway microbiome is associated with decreased diversity
por: Hahn, Andrea, et al.
Publicado: (2018)

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation
por: Hahn, Andrea, et al.
Publicado: (2020)

2573. Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Lung Microbiome Diversity and Pulmonary Function
por: Jason. Bozzella, Michael, et al.
Publicado: (2019)

Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis
por: Hahn, Andrea, et al.
Publicado: (2019)

Benchmark Evaluation of True Single Molecular Sequencing to Determine Cystic Fibrosis Airway Microbiome Diversity
por: Hahn, Andrea, et al.
Publicado: (2018)

Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study
por: Hahn, Andrea, et al.
Publicado: (2020)

Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis
por: Kennedy, Charles, et al.
Publicado: (2022)

Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis
por: Hahn, Andrea, et al.
Publicado: (2023)

Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
por: Koumbourlis, Anastassios C., et al.
Publicado: (2020)

Characteristics and outcomes of oral antibiotic treated pulmonary exacerbations in children with cystic fibrosis()
por: Hoppe, Jordana E., et al.
Publicado: (2018)

Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosis
por: Wagner, Brandie D., et al.
Publicado: (2021)

Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis
por: Hoppe, Jordana E., et al.
Publicado: (2017)

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
por: Zemanick, Edith T., et al.
Publicado: (2013)

Lung Microbiome in Cystic Fibrosis
por: Scialo, Filippo, et al.
Publicado: (2021)

Infection, Allergy, and Inflammation: The Role of Aspergillus fumigatus in Cystic Fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2023)

Fungal Infection and Inflammation in Cystic Fibrosis
por: Poore, T. Spencer, et al.
Publicado: (2021)

Unraveling the CFTR Function–Phenotype Connection for Precision Treatment in Cystic Fibrosis
por: Zemanick, Edith T., et al.
Publicado: (2019)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

Lung ultrasound for the diagnosis of cystic fibrosis pulmonary exacerbation
por: Hassanzad, Maryam, et al.
Publicado: (2021)

Microbial Volatiles as Diagnostic Biomarkers of Bacterial Lung Infection in Mechanically Ventilated Patients
por: Ahmed, Waqar M, et al.
Publicado: (2022)

Nasopharyngeal Microbiome Diversity Changes over Time in Children with Asthma
por: Pérez-Losada, Marcos, et al.
Publicado: (2017)

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
por: Heirali, Alya A., et al.
Publicado: (2017)

Lung Clearance Index in Children with Cystic Fibrosis during Pulmonary Exacerbation
por: Walicka-Serzysko, Katarzyna, et al.
Publicado: (2021)

Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis
por: Byun, Min Kwang, et al.
Publicado: (2017)

Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis
por: Dmitrijeva, Marija, et al.
Publicado: (2021)

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
por: Vandeplassche, Eva, et al.
Publicado: (2019)

The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Cuthbertson, Leah, et al.
Publicado: (2021)

Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa
por: Goolam Mahomed, T., et al.
Publicado: (2021)

Intestinal Lesions Are Associated with Altered Intestinal Microbiome and Are More Frequent in Children and Young Adults with Cystic Fibrosis and Cirrhosis
por: Flass, Thomas, et al.
Publicado: (2015)

2578. Trends in Pathogens and Antibiotic Treatment in Children with Cystic Fibrosis in 2018 and 2022: A Retrospective Multicenter Study
por: Stout, Dayna, et al.
Publicado: (2023)

Neutrophilic proteolysis in the cystic fibrosis lung correlates with a pathogenic microbiome
por: Quinn, Robert A., et al.
Publicado: (2019)

Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
por: Neerincx, Anne H., et al.
Publicado: (2021)

Lung Function in Women With and Without Human Immunodeficiency Virus
por: Wang, Richard J, et al.
Publicado: (2022)

Association between Cystic Fibrosis exacerbations, lung function, T2 inflammation and microbiological colonization
por: Albon, Dana, et al.
Publicado: (2023)

Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline
por: Bacci, Giovanni, et al.
Publicado: (2016)

AtbFinder Diagnostic Test System Improves Optimal Selection of Antibiotic Therapy in Persons with Cystic Fibrosis
por: Tetz, G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p7bvkuv5oodmv6rh2jphrclssi